Analysis of Orpea SA (ORPEF)
Orpea SA is showing a consistent price of 10.00 across multiple days. The Relative Strength Index (RSI) is extremely high at 99.89, indicating that the stock may be overbought. The Moving Average Convergence Divergence (MACD) indicator is positive, with the MACD line above the signal line and a positive MACD histogram. This suggests a bullish momentum in the stock.
The Moving Average (MA) indicator is also showing an upward trend, with the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) all increasing over time.
Overall, based on the technical indicators, Orpea SA seems to be in a strong bullish trend. However, investors should be cautious of the extremely high RSI, which may indicate a potential reversal in the near future.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for the quarter ending on October 31, 2024, were not provided on time. However, on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has a strong operating cash flow and levered free cash flow. The balance sheet shows a healthy current ratio, but a high total debt to equity ratio. The profit margin and operating margin are both positive, indicating profitability. The company's fiscal year ends in September 2023, with notable figures such as revenue, EBITDA, and net income.
Moving on to stock statistics, key metrics include short ratio, float shares, shares outstanding, and insider and institutional ownership percentages. The company's stock price summary provides information on beta, moving averages, and the range of the stock price over the past year.
Valuation metrics show metrics such as P/E ratio, PEG ratio, price to book, and enterprise value multiples. The market capitalization is also provided.
Lastly, dividends and splits information includes details on dividend rates, payout ratios, dividend dates, and historical split information.
Income statement 💸
These are the revenue figures. Here are the conclusions:
1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023, showing a healthy growth in profitability.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years, indicating growth in shareholder value.
7. The company has been able to maintain a stable diluted shares outstanding figure, which is important for EPS calculations.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and shows a growth trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, peaking at $234,386,000,000 in 2018.
4. Total liabilities have also been on the rise, with the highest value in 2018 at $255,355,000,000.
5. Shareholders' equity has generally increased, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to support its operations.
7. There is a consistent increase in retained earnings over the years.
8. The company has been managing its short-term debt effectively, as it has not shown a significant increase despite the growth in total assets.
9. Overall, the financial health of the company seems to be improving, with a steady increase in shareholders' equity and total assets.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities show a pattern of common stock repurchases and long-term debt issuances, with significant variations in these activities across the years.
4. Investing activities reflect a mix of acquisitions, capital expenditures, and investments, with notable changes in the sale and purchase of investments.
5. The end cash position has also varied, reaching its peak in 2020 and its lowest point in 2022.
6. Interest paid and income tax paid figures have fluctuated, impacting the overall cash flow position of the company.
7. The company has been consistent in paying dividends to shareholders, with varying amounts each year.
These conclusions provide insights into the company's financial performance and strategic decisions over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS is projected to be $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, analysts forecast an average EPS of $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the current year.
Overall, the analysts' estimates indicate a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The estimated average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest that the company has been experiencing strong growth in the past but is expected to see a slightly lower growth rate in the coming years, although still positive. It's important to note that these are analyst estimates and actual performance may vary.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median forecast of $201.43 and an average forecast of $204.58. However, it's worth noting that there is a wide range of forecasts, from a low of $164 to a high of $275. The current price of the security is $192.25, which is below both the median and average forecasted prices.MACD of ORPEF